← All trials
NCT02965092
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 2, 2015
- Primary completion
- Jan 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- Nov 16, 2016
- Last posted
- May 10, 2019
- Enrollment
- 80
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Wuhan Sian Medical Technology Co., LtdLead sponsor
- Huazhong University of Science and TechnologyCollaborator
- Huazhong University of Science and TechnologyOverall official - principal investigator
- Central South UniversityCollaborator
- Jingzhou Central HospitalCollaborator
- People's Hospital Of YichangCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.